Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.65 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | TGM2 | P21980 | 12/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL645427 | 1.00 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL7973204 | 1.00 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL20503668 | 1.00 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL20503696 | 1.00 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL20503620 | 1.00 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL20503608 | 1.00 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL20503659 | 1.00 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL20503580 | 1.00 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL20503561 | 1.00 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL9359066 | 1.00 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180333345-A1 | NON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2018-11-22 | — | — | US | claimed |
| EP-3377547-A1 | ON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | ISP Investments LLC (US) | 2018-09-26 | — | — | EP | claimed |
| US-10632059-B2 | Non-aqueous compositions of polymers derived from monomers having acryloyl moiety and lactam moiety and applications thereof | ISP INVESTMENTS LLC (US) | 2020-04-28 | — | — | US | disclosed |
| US-20180333345-A1 | NON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2018-11-22 | — | — | US | disclosed |
| EP-3377547-A1 | ON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | ISP Investments LLC (US) | 2018-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10632059-B2 | Non-aqueous compositions of polymers derived from monomers having acryloyl moiety and lactam moiety and applications thereof | C9, PARG, C5 | ZDHHC20 1306/4885ZDHHC2 3290/4885TSHR 4135/4885 |
| US-20180333345-A1 | NON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | C9, C5, C1S | ZDHHC20 1566/4885ZDHHC2 3377/4885TSHR 4056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.